Kimberly Kubick
Nurse Practitioner · Anchorage, AKNPI 1821171364
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 31.3% of the total. Reporting peaked in 2024 at $630 and has fallen 50.6% since, to $311 in 2025. Among nurse practitioner clinicians in AK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 139 payments — averaging $19.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$849
- Novo Nordisk$564
- Lilly USA, LLC$237
- Antares Pharma, Inc.$197
- AstraZeneca$193
- Endo Pharmaceuticals Inc.$97
- plus $580 from 15 others
What the payments were for
- Food & beverage$2,716100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 41 | $849 |
| Novo Nordisk | 31 | $564 |
| Lilly USA, LLC | 13 | $237 |
| Antares Pharma, Inc. | 9 | $197 |
| AstraZeneca(2 entities) | 10 | $193 |
| Endo Pharmaceuticals Inc. | 5 | $97 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $78 |
| Biohaven Pharmaceuticals, Inc. | 4 | $71 |
| Pfizer | 3 | $60 |
| Astellas Pharma US Inc | 2 | $51 |
| QOL Medical, LLC | 2 | $49 |
| Merck | 3 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $37 |
| Eisai Inc. | 2 | $33 |
| Amarin Pharma, Inc. | 2 | $31 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Pharmacosmos Therapeutics Inc. | 1 | $24 |
| Bayer | 1 | $20 |
| Halozyme Inc | 1 | $19 |
| Organogenesis Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$125
How this compares
$2,716 in reported general payments places this provider in the 95th percentile of 212 nurse practitioner providers in Alaska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omega-3 Acid Ethyl Esters | 18 | $1,087 |
| Testosterone Cypionate | 25 | $986 |
| Np ThyroidThyroid,pork | 11 | $795 |
| Liothyronine Sodium | 14 | $434 |
| Bupropion XlBupropion Hcl | 12 | $349 |
| Ipratropium Bromide | 12 | $217 |
| Lisinopril | 15 | $212 |
| Anastrozole | 15 | $206 |
| Amlodipine Besylate | 13 | $190 |
| Metformin Hcl | 13 | $151 |
| Diazepam | 12 | $20 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Anchorage
- Wezzie MunthaliAnchorage$4K
- Lily GeorgeAnchorage$4K
- Genevieve CorbettAnchorage$3K
- Terri TopeAnchorage$2K
- Jimin HwangAnchorage$2K
- Betty BangAnchorage$2K
- Christine WalrathAnchorage$917
- Jaclyn HousleyAnchorage$835
- Katherine KellyAnchorage$831
- Yukiko GoodellAnchorage$818
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.